Caixin
Mar 28, 2023 08:00 AM

Huaren Pharmaceutical Co.,Ltd.’s Net Profit Rose 35.3% in 2022

Huaren Pharmaceutical Co.,Ltd. (华仁药业股份有限公司) (300110.SZ) reported a net profit of 181.3 million yuan in 2022, up 35.3% year-on-year.

Meanwhile, the company posted 1.6 billion yuan in revenue, up 3.8% year-on-year.

At the end of the reporting period, it had 5.2 billion yuan in total assets and 2.6 billion yuan in total liabilities, with a liability-to-asset ratio of 49.6%.

This article was automatically produced by Caixin Automation on April 27, 2023.

Download our app to receive breaking news alerts and read the news on the go.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST